
Lidocaine Base is used in topical formulations that rely on skin penetration
Lidocaine Base is a key Active Pharmaceutical Ingredient (API) belonging to the Amide-Type Local Anesthetics class. It is characterized by its rapid and extended efficacy in providing temporary local anesthesia and nerve blocks. Unlike its Hydrochloride salt (HCl), Lidocaine Base is primarily used in non-aqueous formulations and topical preparations (dermal and mucosal) where effective skin penetration is required.
Topical preparations for dermatology and surface anesthesia.
The base form, with its limited water solubility, ensures easy integration and stability within oily/fatty bases.
Anorectal and rectal formulations.
Excellent stability and compatibility with common suppository fatty bases.
Transdermal delivery systems.
The Lipophilic characteristics facilitate skin penetration for effective localized action.
The product conforms to the specified requirements of the United States Pharmacopeia (USP), European Pharmacopoeia (EP), and/or British Pharmacopoeia (BP).
A detailed CoA is issued with every batch, outlining potency, purity profile, and microbiological testing verification.
A comprehensive Drug Master File is available to support registration submissions to regulatory authorities worldwide.
Production takes place in certified facilities that strictly adhere to current Good Manufacturing Practices (cGMP).